Sed vertebral fracture within the elderly 12- and 22-year follow-up of 257 patients. Calcif Tissue Int. 2005;76(4):2352. six. Turner CH, Sato M, Bryant HU. Raloxifene preserves bone strength and bone mass in ovariectomized rats. Endocrinology. 1994;135(five):2001. 7. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, et al. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol with no causing uterine hypertrophy in ovariectomized rats. J Clin Invest. 1994;93(1):63. 8. Clemens JA, Bennett DR, Black LJ, Jones CD. Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels. Life Sci. 1983;32(25):28695. 9. Anzano MA, Peer CW, Smith JM, Mullen LT, Shrader MW, Logsdon DL, et al. Chemoprevention of mammary carcinogenesis within the rat: combined use of raloxifene and 9-cis-retinoic acid. J Natl Cancer Inst. 1996;88(2):123.Su et al. BMC Musculoskeletal Issues (2015) 16:Page five of10. Brown JP, Josse RG. clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ : Canadian Healthcare Association journal = journal de l’Association medicale canadienne 2002. 2002;167(10 Suppl):S14. 11. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal girls: results in the National Osteoporosis Threat Assessment.Bolm’s ligand supplier Jama.876379-79-2 Chemscene 2001;286(22):28152.PMID:23310954 12. Hajcsar EE, Hawker G, Bogoch ER. Investigation and therapy of osteoporosis in patients with fragility fractures. CMAJ : Canadian Healthcare Association journal = journal de l’Association medicale canadienne. 2000;163(7):8192. 13. Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med. 2000;109(4):326. 14. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity J Bone Joint Surg Am. 2000;82-A(eight):10630. 15. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, et al. Risk of new vertebral fracture in the year following a fracture. Jama. 2001;285(three):320. 16. Shiraki M, Kuroda T, Tanaka S. Established osteoporosis linked with higher mortality just after adjustment for age and co-mobidities in postmenopausal Japanese women. Intern Med. 2011;50(5):39704. 17. Ismail AA, O’Neill TW, Cooper C, Finn JD, Bhalla AK, Cannata JB, et al. Mortality associated with vertebral deformity in guys and females: benefits in the European Prospective Osteoporosis Study (EPOS). Osteoporos Int. 1998;eight(three):291. 18. Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O. Prevalent vertebral deformities predict increased mortality and elevated fracture rate in each males and girls: a 10-year population-based study of 598 people in the Swedish cohort within the European Vertebral Osteoporosis Study. Osteoporos Int. 2003;14(1):61. 19. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kanis JA, Selby P, et al. Association between vertebral fracture and enhanced mortality in osteoporotic patients. J Bone Miner Res Off J Am Soc Bone Miner Res. 2003;18(7):12540. 20. Naves M, Diaz-Lopez JB, Gomez C, Rodriguez-Rebollar A, Rodriguez-Garcia M, Cannata-Andia JB. The impact of vertebral fracture as a risk element for osteoporotic fracture and mortality inside a Spanish population. Osteoporos Int. 2003;14(6):520. 21. Nguyen ND, Ahlborg HG, Center JR, Eisman J.
